Mamounas, E. P., Tang, G., Puhalla, S. L., Swain, S. M., Ganz, P. A., Henry, N. L., Cecchini, R. S., Reid, S. A., Rastogi, P., Geyer, C. E., White, J. R., Clark, A. S., Haddad, T. C., Vidal, G. A., Wolmark, N. (2026). A phase III trial evaluating addition of adjuvant chemotherapy to ovarian function suppression + endocrine therapy in premenopausal women with pN0-1, HR+/HER2– breast cancer and Oncotype recurrence score ≤ 25 (OFSET): NRG-BR009.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps650